- Home
- EPD vs GSK Comparison
EPD vs GSK Comparison
Compare EPD & GSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPD
- GSK
- Stock Information
- Founded
- EPD 1968
- GSK 1715
- Country
- EPD United States
- GSK United Kingdom
- Employees
- EPD N/A
- GSK N/A
- Industry
- EPD Natural Gas Distribution
- GSK Biotechnology: Pharmaceutical Preparations
- Sector
- EPD Utilities
- GSK Health Care
- Exchange
- EPD Nasdaq
- GSK Nasdaq
- Market Cap
- EPD 68.2B
- GSK 77.1B
- IPO Year
- EPD 1998
- GSK N/A
- Fundamental
- Price
- EPD $31.72
- GSK $39.98
- Analyst Decision
- EPD Buy
- GSK Hold
- Analyst Count
- EPD 13
- GSK 2
- Target Price
- EPD $36.00
- GSK N/A
- AVG Volume (30 Days)
- EPD 4.3M
- GSK 3.5M
- Earning Date
- EPD 07-28-2025
- GSK 07-30-2025
- Dividend Yield
- EPD 6.88%
- GSK 4.06%
- EPS Growth
- EPD 2.20
- GSK N/A
- EPS
- EPD 2.68
- GSK 1.13
- Revenue
- EPD $54,756,000,000.00
- GSK $43,336,073,439.00
- Revenue This Year
- EPD N/A
- GSK $5.66
- Revenue Next Year
- EPD $9.50
- GSK $5.13
- P/E Ratio
- EPD $11.82
- GSK $35.19
- Revenue Growth
- EPD N/A
- GSK 0.59
- 52 Week Low
- EPD $27.77
- GSK $31.72
- 52 Week High
- EPD $34.63
- GSK $44.67
- Technical
- Relative Strength Index (RSI)
- EPD 54.19
- GSK 60.08
- Support Level
- EPD $31.37
- GSK $39.57
- Resistance Level
- EPD $32.00
- GSK $40.57
- Average True Range (ATR)
- EPD 0.39
- GSK 0.49
- MACD
- EPD 0.03
- GSK 0.15
- Stochastic Oscillator
- EPD 58.41
- GSK 78.28
About EPD Enterprise Products Partners L.P.
Enterprise Products Partners is a master limited partnership that transports and processes natural gas, natural gas liquids, crude oil, refined products, and petrochemicals. It is one of the largest midstream companies, with operations servicing most producing regions in the continental US. Enterprise is particularly dominant in the NGL market and is one of the few MLPs that provide midstream services across the full hydrocarbon value chain.
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.